Patents by Inventor Kenneth F. May,, Jr.

Kenneth F. May,, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic peptides
    Patent number: 10793633
    Abstract: The present disclosure provides, in part, compositions comprising peptides that immunospecifically bind to a defined binding partner, such as MHC class I polypeptide-related sequence A (MICA), or an epitope thereon. In some embodiments, the peptides comprise one or more complementarity determining regions relating to the complementarity regions shown in Table 1. The disclosure also provides methods of treating cancer in a subject using the compositions disclosed herein, and methods of isolating human antibodies from cancer patients following immunotherapy.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: October 6, 2020
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Kai W. Wucherpfennig, Bettina Franz, Kenneth F. May, Jr., Glenn Dranoff, F. Stephen Hodi, Christopher Harvey
  • Therapeutic peptides
    Patent number: 10745483
    Abstract: The present disclosure provides, in part, compositions comprising peptides immuno specifically binds to defined binding partners, wherein the peptides comprise at least complementarity determining regions relating to the complementarity regions shown in Table 1.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 18, 2020
    Assignee: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Kai W. Wucherpfennig, Glenn Dranoff, F. Stephen Hodi, Bettina Franz, Kenneth F. May, Jr., Christopher Harvey
  • Antibodies that bind to MHC class I polypeptide-related sequence A
    Patent number: 10106611
    Abstract: The present disclosure provides, in part, compositions comprising peptides immunospecifically binds to MHC class I polypeptide-related sequence A (MICA).
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: October 23, 2018
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Kai W. Wucherpfennig, Glenn Dranoff, F. Stephen Hodi, Bettina Franz, Kenneth F. May, Jr., Christopher Harvey
  • THERAPEUTIC PEPTIDES
    Publication number: 20170022275
    Abstract: The present disclosure provides, in part, compositions comprising peptides immunospecifically binds to MHC class I polypeptide-related sequence A (MICA).
    Type: Application
    Filed: December 5, 2014
    Publication date: January 26, 2017
    Inventors: Kai W. WUCHERPFENNIG, Glenn DRANOFF, F. Stephen HODI, Bettina FRANZ, Kenneth F. MAY, JR., Christopher HARVEY
  • THERAPEUTIC PEPTIDES
    Publication number: 20170008962
    Abstract: The present disclosure provides, in part, compositions comprising peptides immunospecifically binds to defined binding partners, wherein the peptides comprise at least complementarity determining regions relating to the complementarity regions shown in Table 1.
    Type: Application
    Filed: July 15, 2016
    Publication date: January 12, 2017
    Inventors: Kai W. WUCHERPFENNIG, Bettina FRANZ, Kenneth F. MAY, JR., Glenn DRANOFF, F. Stephen HODI, Christopher HARVEY
  • Therapeutic peptides
    Patent number: 9402905
    Abstract: The present disclosure provides, in part, compositions comprising an antibody or antibody fragment that immunospecifically binds to MCH class I polypeptide-related sequence A (MICA), or an epitope thereof.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: August 2, 2016
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Kai W. Wucherpfennig, Bettina Franz, Kenneth F. May, Jr., Glenn Dranoff, F. Stephen Hodi, Christopher Harvey
  • THERAPEUTIC PEPTIDES
    Publication number: 20160046716
    Abstract: The present disclosure provides, in part, compositions comprising peptides immuno specifically binds to defined binding partners, wherein the peptides comprise at least complementarity determining regions relating to the complementarity regions shown in Table 1.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 18, 2016
    Inventors: Kai W. WUCHERPFENNIG, Glenn DRANOFF, F. Stephen HODI, Bettina FRANZ, Kenneth F. MAY, Jr., Christopher HARVEY
  • Therapeutic Peptides
    Publication number: 20140004112
    Abstract: The present disclosure provides, in part, compositions comprising peptides immunospecifically binds to defined binding partners, wherein the peptides comprise at least complementarity determining regions relating to the complementarity regions shown in Table 1.
    Type: Application
    Filed: September 12, 2013
    Publication date: January 2, 2014
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Kai W. Wucherpfennig, Bettina Franz, Kenneth F. May,, Jr., Glenn Dranoff, F. Stephen Hodi, Christopher Harvey